Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04179 (
MnSOD
)
2,777
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Overexpression of c-Myc or
E2F1
sensitizes host cells to various types of apoptosis. Here, we found that overexpressed c-Myc or
E2F1
induces accumulation of reactive oxygen species (ROS) and thereby enhances serum-deprived apoptosis in NIH3T3 and Saos-2. During serum deprivation,
MnSOD
mRNA was induced by NF-kappaB in mock-transfected NIH3T3, while this induction was inhibited in NIH3T3 overexpressing c-Myc or
E2F1
. In these clones,
E2F1
inhibited NF-kappaB activity by binding to its subunit p65 in competition with a heterodimeric partner p50. In addition to overexpressed
E2F1
, endogenous
E2F1
released from Rb was also found to inhibit NF-kappaB activity in a cell cycle-dependent manner by using
E2F1
(+/+) and
E2F1
(-/-) murine embryonic fibroblasts. These results indicate that
E2F1
promotes apoptosis by inhibiting NF-kappaB activity.
...
PMID:E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. 1204 38
E2F1
and FOXO3 are two transcription factors that have been shown to participate in cellular senescence. Previous report reveals that
E2F1
enhanced cellular senescence in human fibroblast cells, while FOXO transcription factors play against senescence by regulation reactive oxygen species scavenging proteins. However, their functional interplay has been unclear. Here we use
E2F1
knock-out murine Embryonic fibroblasts (MEFs), knockdown RNAi constructs, and ectopic expression of
E2F1
to show that it functions by negatively regulating FOXO3.
E2F1
attenuates FOXO3-mediated expression of
MnSOD
and Catalase without affecting FOXO3 protein stability, subcellular localization, or phosphorylation by Akt. We mapped the interaction between
E2F1
and FOXO3 to a region including the DNA binding domain of
E2F1
and the C-terminal transcription-activation domain of FOXO3. We propose that
E2F1
inhibits FOXO3-dependent transcription by directly binding FOXO3 in the nucleus and preventing activation of its target genes. Moreover, knockdown of the Caenorhabditis elegans
E2F1
ortholog efl-1 significantly extends lifespan in a manner that requires the activity of the C. elegans FOXO gene daf-16. We conclude that there is an evolutionarily conserved signaling connection between
E2F1
and FOXO3, which regulates cellular senescence and aging by regulating the activity of FOXO3. We speculate that drugs and/or therapies that inhibit this physical interaction might be good candidates for reducing cellular senescence and increasing longevity.
...
PMID:E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors. 2534 4